Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases

Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases

US Patent 7771726 · Granted Aug 10, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific HIV-1-neutralizing antibodies2024
Tri-specific antibodies for HIV therapy2020
Bispecific HIV-1-neutralizing antibodies2019
Bispecific HIV-1 neutralizing antibodies2018
Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and gly2017
Bispecific HIV-1 neutralizing antibodies2017
Modification of recombinant adenovirus with immunogenic plasmodium circumsporozo2017
Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and gly2016
Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as2015
C—glycolipids with enhanced Th-1 profile2014
C—glycolipids with enhanced Th-1 profile2014
Codon-optimized DNA molecules encoding the receptor binding domains of Clostridi2014